Publisher Full Text
Severe Rhabdomyolysis in a 35-Year-old Woman with COVID-19 due to SARS-CoV-2 Infection: A Case Report.Am J Case Rep. 2020 Aug 17; 21:e926733.AJ
Abstract
BACKGROUND
Rhabdomyolysis is a skeletal muscle injury that has different etiologies and can be a manifestation of coronavirus disease 2019 (COVID-19). Because it is a life-threatening condition, rapid diagnosis is necessary to prevent acute complications. Diagnostic criteria for rhabdomyolysis are elevated serum creatine kinase, liver enzyme levels, and myalgia. Rhabdomyolysis can easily be missed in patients with COVID-19. Herein, we report the case of a female with rhabdomyolysis as a manifestation of acute COVID-19. CASE REPORT A 35-year-old female was found to have rhabdomyolysis associated with COVID-19. Her creatine kinase and liver enzyme levels were significantly elevated. Ringer's lactate infusion was administered at a controlled rate to treat the rhabdomyolysis along with boluses of normal saline, with close monitoring of her oxygen saturation and kidney function. The patient's creatine kinase and liver enzyme levels peaked on Day 2 and then decreased. Her medical condition improved, and she was discharged on Day 4.CONCLUSIONS
Our case highlights the need to monitor the creatine kinase level of hospitalized patients with COVID-19. Fluid management can be challenging in patients with rhabdomyolysis due to COVID-19 because of the risk of fluid overload and acute respiratory distress syndrome. Clinicians should be aware that a significant elevation in liver enzyme levels and myalgia can be the presenting features of rhabdomyolysis in patients with COVID-19.Links
MeSH
Pub Type(s)
Case Reports
Journal Article
Language
eng
PubMed ID
32801291
Citation
Alrubaye, Riyadh, and Hasan Choudhury. "Severe Rhabdomyolysis in a 35-Year-old Woman With COVID-19 Due to SARS-CoV-2 Infection: a Case Report." The American Journal of Case Reports, vol. 21, 2020, pp. e926733.
Alrubaye R, Choudhury H. Severe Rhabdomyolysis in a 35-Year-old Woman with COVID-19 due to SARS-CoV-2 Infection: A Case Report. Am J Case Rep. 2020;21:e926733.
Alrubaye, R., & Choudhury, H. (2020). Severe Rhabdomyolysis in a 35-Year-old Woman with COVID-19 due to SARS-CoV-2 Infection: A Case Report. The American Journal of Case Reports, 21, e926733. https://doi.org/10.12659/AJCR.926733
Alrubaye R, Choudhury H. Severe Rhabdomyolysis in a 35-Year-old Woman With COVID-19 Due to SARS-CoV-2 Infection: a Case Report. Am J Case Rep. 2020 Aug 17;21:e926733. PubMed PMID: 32801291.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Severe Rhabdomyolysis in a 35-Year-old Woman with COVID-19 due to SARS-CoV-2 Infection: A Case Report.
AU - Alrubaye,Riyadh,
AU - Choudhury,Hasan,
Y1 - 2020/08/17/
PY - 2020/8/18/entrez
PY - 2020/8/18/pubmed
PY - 2020/9/2/medline
SP - e926733
EP - e926733
JF - The American journal of case reports
JO - Am J Case Rep
VL - 21
N2 - BACKGROUND Rhabdomyolysis is a skeletal muscle injury that has different etiologies and can be a manifestation of coronavirus disease 2019 (COVID-19). Because it is a life-threatening condition, rapid diagnosis is necessary to prevent acute complications. Diagnostic criteria for rhabdomyolysis are elevated serum creatine kinase, liver enzyme levels, and myalgia. Rhabdomyolysis can easily be missed in patients with COVID-19. Herein, we report the case of a female with rhabdomyolysis as a manifestation of acute COVID-19. CASE REPORT A 35-year-old female was found to have rhabdomyolysis associated with COVID-19. Her creatine kinase and liver enzyme levels were significantly elevated. Ringer's lactate infusion was administered at a controlled rate to treat the rhabdomyolysis along with boluses of normal saline, with close monitoring of her oxygen saturation and kidney function. The patient's creatine kinase and liver enzyme levels peaked on Day 2 and then decreased. Her medical condition improved, and she was discharged on Day 4. CONCLUSIONS Our case highlights the need to monitor the creatine kinase level of hospitalized patients with COVID-19. Fluid management can be challenging in patients with rhabdomyolysis due to COVID-19 because of the risk of fluid overload and acute respiratory distress syndrome. Clinicians should be aware that a significant elevation in liver enzyme levels and myalgia can be the presenting features of rhabdomyolysis in patients with COVID-19.
SN - 1941-5923
UR - https://www.unboundmedicine.com/medline/citation/32801291/Severe_Rhabdomyolysis_in_a_35_Year_old_Woman_with_COVID_19_due_to_SARS_CoV_2_Infection:_A_Case_Report_
L2 - https://www.amjcaserep.com/download/index/idArt/926733
DB - PRIME
DP - Unbound Medicine
ER -